Rate the quality and effectiveness of each of the following Speakers:
Sunday, June 16, 2013 / Excellent / Good / Average / Fair / PoorNMDA antagonists: Therapeutic implications and abuse liability
- Mark Niciu: Rapid and sustained antidepressant effects of ketamine: Therapeutic implications
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Rae Matsumoto: Role of sigma receptors in antidepressant-like effects of ketamine
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- J. Beckman:The role of NMDA glutamate receptors in models of abuse vulnerability
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- William Fantegrossi: Novel eticyclidine analogues as emerging drugs of abuse
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Robert Balster: Discussant: Historical perspectives on NMDA antagonists as drugs of abuse and as therapeutics
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
WHAT DO WE REALLY KNOW ABOUT THE IMPACTS OF MEDICAL MARIJUANA? RESEARCH EXPLORING POLICIES ACROSS AMERICA / Excellent / Good / Average / Fair / Poor- R. Booth: Medical marijuana in Denver, Colorado: Voices from theIndustry
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Bridget Freisthler:Medical marijuana dispensaries andmarijuana use: Evidence from 50 cities in California
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Mark Greenwald: Behavioral economic analysis of therapeutic and non-therapeutic marijuana use in HIV/AIDS patients
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Rosalie Pacula: The impact of medical marijuana policies on publichealth
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Deborah Hasin: Discussant
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
THE INTERTWINING EPIDEMICS OF DRUG USE AND HIV/AIDS: THE HIV/AIDS WORKGROUP / Excellent / Good / Average / Fair / Poor- Hannah Cooper: Public housing relocations and biobehavioral risks of HIV among substance misusers etc
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Daniel Hernandez: Drug treatment experiences among female sex workers and their non-commercial partners along the Mexico-U.S. border
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Christina Meade: Effects of HIV and cocaine on impulsive decision- making: Implications for HIV prevention
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
- Jeffrey Parsons: Association between substance use patterns and HIV medication adherence among HIV-positive older adults
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Elise Riley: Levamisole-contaminated cocaine use is associated with lower levels of prealbumin and white blood cell count in HIV-infected homeless women
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
6. Don Des Jarlais: Crack-cocaine and HIV: Multiple factors of a “perfect storm” in New York City
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
7. Daniel Fuster: Chronic hepatitis C virus infection is associated with all-cause mortality in a cohort of HIV-infected patients with alcohol problems
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
ASSESSMENT OF ABUSE-DETERRENT AND TAMPER-RESISTANT TECHNOLOGIES PART II: NEW DIRECTIONS / Excellent / Good / Average / Fair / Poor1. Michael Klein: Regulatory perspective on abuse-deterrent formulations
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Edward Cone: In vitro assessment of abuse-deterrent formulations
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Naama Levy-Cooperman: Clinical assessment of abuse-deterrent formulations
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Simon Budman: Epidemiological confirmation of abuse deterrence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Edward Sellers: New Guidance: Two steps forward or one step back?
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
Monday, June 17, 2013 / Excellent / Good / Average / Fair / PoorTHE INTERACTION BETWEEN ALCOHOL AND OTHER DRUGS OF ABUSE: FROM NEUROBIOLOGY TO CLINICAL IMPLICATIONS
1. Selena Bartlett: Developing treatments for alcohol and nicotine addiction by targeting nicotinic receptor subunits
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Ivan Diamond: Craving and relapse in alcoholism and cocaine addiction: Molecular medicine for a persistent malady
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. AndrewHolmes: Endocannabinoid modulation of alcohol’s behavioral actions
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Marcus Heilig: Central opioid systems as mediators of ethanol reinforcement—A pharmacogenetic view
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Eric Strain: The interaction between alcohol and other drugs of abuse: Summary and discussion
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
NEW DIRECTIONS IN THE PHARMACOLOGICAL FACILITATION OF PSYCHOTHERAPY FOR DRUG DEPENDENCE / Excellent / Good / Average / Fair / Poor1. Roland Griffths: Psilocybin and quantum change experiences: Implications for treatment of drug dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Michael Bogenschutz: Psilocybin-facilitated treatment of alcohol dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Matthew Johnson: Facilitation of cognitive behavioral therapy for smoking cessation using the 5-HT2A agonist psilocybin
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Elias Dakwar: Ketamine-facilitated treatment of cocaine dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Herbert Kleber: Discussant: The promise and pitfalls of drug-facilitated psychotherapy for treatment of drug dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
NEW SCIENCE AND TOOLS TO IMPROVE THE DIAGNOSIS, PREVENTION AND TREATMENT OF HEPATITIS C VIRUS AND ITS SEQUELAE / Excellent / Good / Average / Fair / Poor
1. Alain Litwin: Intensive hepatitis C treatment
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Brian Edlin: Integrated vs. separate care for hepatitis C, substance abuse and HIV prevention
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Bruce Shackman: Economic analysis of rapid HIV, HCV testing
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
SEX HORMONE MODULATION OF NICOTINE REWARD: EFFECTS ON URGES, AFFECT, PHYSIOLOGICAL RESPONSE, AND BRAIN ACTIVATION / / / / /
1. Alicia Allen: Allopregnanolone and smoking-related symptomatology during smoking cessation in premenopausal women
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Elise DeVito: Influences of gonadal hormones and sex on responses to intravenous nicotine
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Teresa Franklin: Hormonal effects on the brain’s response to smoking CUES: A perfusion FMRI study
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
PHARMACOTHERAPEUTIC TARGETING OF GLUTAMATERGIC SIGNALING IN THE REVERSAL OF ADDICTION PATHOLOGY / / / / /
1. Cassandra Gipson: Rapid synaptic potentiation and alterations in glutamatergic signaling: New pharmacotherapeutic targets in reversing nicotine addiction
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Athina Markou: mGlu2 and mGlu7 receptors as targets for nicotine dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Erin McClure: Tobacco outcomes during an N-Acetylcysteine-assisted cannabis cessation trial in adolescents
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
THE 19TH ANNUAL CONTINGENCY MANAGEMENT WORKING GROUP / Excellent / Good / Average / Fair / Poor
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Poor
TAKE-HOME NALOXONE TO ADDRESS OPIOID OVERDOSE: STATE OF THE EVIDENCE AND METHODS
1. Alexander Walley: Opioid overdose rates in Massachusetts after the implementation of overdose education and intranasal naloxone distribution / Excellent / Good / Average / Fair
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Phillip Coffin: Mathematical modeling of opioid overdose and naloxone distribution: Cost-effectiveness and population outcomes
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Traci Green: Feasibility of prison-based overdose prevention education and prescribed naloxone at release
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Caleb Banta-Green: Design of a randomized trial of overdose education and naloxone distribution
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Sheila Bird: Experimental and observational methods to determine the effectiveness of naloxone distribution for reducing opioid overdose fatalities: The N-ALIVE randomized controlled trial in England and take-home naloxone as public health policy in Scotland
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
THE INTERPLAY OF THE JUVENILE JUSTICE AND ADOLESCENT TREATMENT SYSTEMS AND HOW TO USE EVIDENCED-BASED ASSESSMENT, TREATMENT AND IMPLEMENTATION PRACTICES TO IMPROVE OUTCOMES / Excellent / Good / Average / Fair / Poor1. Vinetha Belur: Using the GAIN Short Screener (GAIN_SS) to predicting recidivism among of juvenile offenders in adolescent treatment
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Michael Dennis: The changes in the pattern and cost of the crime among juveniles presenting to treatment
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Laura Niessen: Evaluating the impact of adding the reclaiming futures approach to juvenile treatment drug courts
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Craig Henderson:Moderator effects of gender and ethnicity across multidimensional family therapy randomized controlled trials in community and justice settings: An integrative data analysis
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Redonna Chandler: Overview of NIDA’s new Translational Research on Interventions for Adolescents in the Legal System (TRIALS) cooperative agreement
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
EVALUATING AND MINIMIZING THE RISK, MISUSE AND DIVERSION OF PRESCRIPTION DRUG USE IN YOUTH / Excellent / Good / Average / Fair / Poor
1. Linda Cottler: Diverters of prescription stimulants among a national sample of 11,000 10- to 18-year-olds: Demographic and psychiatric risk factors
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Catherine Striley: Multicomorbid drug use among young prescription stimulant users, misusers and diverters
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. C. Ruktanonchai: Ideas to reduce risk for Rx opioid and stimulants among 11,000 youth: From their own voices
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Theodore Cicero: Ongoing surveillance in real time of misuse and diversion of Rx opioids
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Sidney Schnoll: How to reduce misuse and diversion of Rx drugs among youth
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Tuesday, June 18, 2013 / Excellent / Good / Average / Fair / Poor
PRECLINICAL TO CLINICAL EVIDENCE THAT GLIA AND NEUROINFLAMMATIO: N MEDIATE DRUG ABUSE AND RELATED PATHOLOGIES
1. Kurt Hauser: Astroglia and microglia: Architects in opiate-mediated synaptodendritic injury and behavioral deficits in neuroAIDS
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Patrick Beardsley: Preclinical evidence that chemically modulating glial and neuroinflammatory activity affects drug-maintained and relapse behavior with a focus on methamphetamine
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Sandra Comer: Effects of glial modulators (Ibudilast, Minocycline, and Pioglitazone) on opioid-induced responses in human research volunteers
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Steven Shoptaw: Initial outcomes of a Phase IB, safety interaction trial of Ibudilast as a medication for methamphetamine dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Keith Heinzerling: Brief introduction to current research on glial/neuro-inflammatory processes and drug abuse and summary/discussion of highlights from symposium presentations
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
SUBSTANCE USE: HEALTH AND SOCIAL EFFECTS IN OLDER DRUG USERS: WHAT WE KNOW AND WE DON'T / Excellent / Good / Average / Fair / Poor
1: Nicholas Lintzeris: Substance use and health status in older substance users: Implications for research and practice
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Michelle Lofwall: Trends in non-alcohol substance use among older persons in the United States
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Gillender Bedi: Hippocampal volume and cognitive function in aging cocaine smokers
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Lynne Parkinson: Opioid use and health in older Australian women
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Nicholas Lintzeris: Health status including cognitive state of older opioid/alcohol/BZD substance users attending hospital and community health services
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Animals in Research Forum
/ Excellent / Good / Average / Fair / Poor
1. B. Taylor Bennett
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Rate the quality and effectiveness of each of the following Speakers:
HOW TO GET YOUR ADDICTION RESEARCH MANUSCRIPTS PUBLISHED: GUIDELINES FOR EMERGING INVESTIGATORS / Excellent / Good / Average / Fair / Poor1. Danielle Ramo: Getting published: Junior investigator issues
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Sandra Comer: Planning, targeting, and preparing of manuscripts
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. M. McGovern: Working with journal editors
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Eric Strain: Publishing: After you get your reviews
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Robert Balster: Resources for young investigators
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
NOVEL TOBACCO AND NICOTINE PRODUCTS AND REGULATORY SCIENCE / Excellent / Good / Average / Fair / Poor
1. David Ashley: The Family Smoking Prevention and Tobacco Control Act and regulatory science
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Jack Henningfield: Emerging tobacco products: Perils and potential promise
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Lawrence Carter: Regulatory science: Contributions from drug abuse researchers
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. David Shurleff: Discussant
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
ARE WE MISSING THE MARK WITH GENDER DIFFERENCES, WOMEN SUBSTANCE USERS, AND SOCIAL DETERMINANTS FOR HIV RISK? LESSONS FROM AROUND THE GLOBE / Excellent / Good / Average / Fair / Poor
1. W. Zule: Gender differences among couples using alcohol and drugs in disparate social settings in Cape Town, South Africa
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Irma Kirtadze: Women IDUs in Georgia: Risk and stigma in seeking care and policy implications
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Jennifer Syvertsen: Reconfiguring risk: Gender and injection drug-related HIV risk among female sex workersand their non-commercial partners along the Mexico-U.S. border
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Hendree Jones: Discussant
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
APPROACHES FOR SCREENING AND TREATING RISKY DRUG-USING PATIENTS IN COMMUNITY HEALTH CENTERS / Poor
1. Ronald Andersen: A conceptual model for implementing and evaluating the screening (the ASSIST) and treating (the QUIT) of risky drug users in community health centers
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Lillian Gelberg: mplementing and evaluating the ASSIST to screen for risky untreated drug users in community health centers
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Howard Podwa: Barriers to reducing risky drug use by primary care patients in federally qualified health centers from reducing drug use
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Lillian Gelberg: The efficacy of the QUIT intervention for reducing risky drug use and drug-related harm behavior of patients of community health centers
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Guillermina Natera: Applying the ASSIST/QUIT model to a collaborative Mexico/US study to reduce risky drug use of community clinic patients on both sides of the border
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Wednesday, June 19, 2013 / Excellent / Good / Average / Fair / Poor
EMERGING DATA ON EFFICACY AND CLINICAL APPLICATIONS OF EXTENDED RELEASE NALTREXONE FORMULATIONS
1. E. Krupitsky: Long-acting extended release naltrexone for opioid dependence: Implantable and injectable
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Nikolaj Kunøe: Interest for extended-release naltrexone among opioid users evaluated for participation in the Norwegian XR-NTX vs. buprenorphine-naloxone study
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Valgerdur Runarsdottir: Using naltrexone for treating amphetamine dependence: Preliminary results of the efficacy of extended release naltrexone for treating amphetamine dependence in Iceland
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Gary Kenneth Hulse: The efficacy and safety of the Australian sustained-release naltrexone implant for the management of opioid, amphetamine, and alcohol dependence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Kathleen Brady: Discussant
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
BEHAVIORAL DISINHIBITION, DRUGS OF ABUSE, AND BRAIN DYSFUNCTION IN HUMANS AND RODENT MODELS / Excellent / Good / Average / Fair / Poor
1. Susan Young: Behavioral disinhibition: A continuum of risk for addiction and comorbid externalizing psychopathology
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Thomas Crowley: Behavioral disinhibition: A continuum of risk for addiction and comorbid externalizing psychopathology
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Noelle Anastasio: Behavioral disinhibition: A continuum of risk for addiction and comorbid externalizing psychopathology
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Barry Setlow: Risk-taking, dopamine signaling, and cocaine self-administration
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. J. David Jentsch: Discussant
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
NEW TOOLS PROVIDE NEW INSIGHTS INTO METHAMPHETAMINE'SACTIONS
/ Excellent / Good / Average / Fair / Poor
1. Susan Amara: Meth/amphetamine modulation of intracellular signaling pathways: More about DAT
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Gregory Miller: Trace amine-associated receptor 1 is a methamphetamine receptor that differentially controls DAT and NET internalization
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Jennifer Loftis: Partial MHC/neuroantigen peptide constructs: A potential neuroimmune- based treatment for methamphetamine addiction
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. David Grandy: Trace amine-associated receptor 1 is a methamphetamine receptor in mice
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. David Shurleff: Discussant
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
THIS IS YOUR BRAIN BEFORE DRUGS: NEUROIMAGING HIGH-RISK YOUTH / Excellent / Good / Average / Fair / Poor
1. Mary Heitzeg: THIS IS YOUR BRAIN BEFORE DRUGS: NEUROIMAGING HIGH-RISK YOUTH
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Leslie Hulvershorn: Functional neuroimaging of emotion processing and regulation in high-risk 10 - 14-year-olds
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Joanna Jacobus: Structural brain predictors of adolescent substance use
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
USE IT AND LOSE IT: IMPACT OF A PHARMACOLOGICAL POT POURRI ON THE DEVELOPING BRAIN
/ Excellent / Good / Average / Fair / Poor
1. Staci Gruber: Worth the wait: Early marijuana use is related to alterations in neurocognitive, functional and structural brain correlates
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Krista Lisdahl: Why we need todelay age of alcohol & marijuana use onset: Neurocognitive studies in youth
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Edythe London: Smoking and prefrontal cortex function in late adolescence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Scott Lukas: Challenges of detecting and predicting the consequences of early drug use by adolescents
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
Thursday, June 20, 2013 / Excellent / Good / Average / Fair / Poor
BRAIN FUNCTIONAL CONNECTIVITY AS A BIOMARKER FOR STIMULANT ABUSE
1. Kevin Murnane: Functional brain networks as predictors of cocaine self-administration in nonhuman primates
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
2. Kelvin Lim: What happens to the addicted brain during recovery? Functional connectivity changes during abstinence
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
3. Colleen Hanlon: Differentiating mesocortical and mesolimbic circuitry in cocaine users through interleaved TMS-BOLD imaging: A ‘hybrid’ approach to functional connectivity
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
4. Dardo Tomasi: Resting-state functional connectivity pathways from dopaminergic regions: Disruption in addiction and effects of methylphenidate
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
5. Anna Rose Childress: Heightened intra-limbic connectivity during cocaine cues as treatment target: Modulation by candidate medications
Current Information / / / / /
Objective/Balance / / / / /
Scientific Rigor / / / / /
SPEAKER EVALUATION FORM